Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma, Non-Hodgkin 6Neoplasm Metastasis 3Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Multiple Myeloma 2Lymphoma, Follicular 2Endometrial Neoplasms 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid cancer, follicular 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Spinocerebellar Degenerations 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Renal Insufficiency 1Recurrence 1Ovarian Neoplasms 1Osteosarcoma 1Neuroblastoma 1Malignant Solid Neoplasm 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Leukemia, Lymphoid 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hepatic Insufficiency 1Gallbladder Neoplasms 1Digestive System Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1

Interventions

Dexamethasone 2Azacitidine 2sacubitril and valsartan sodium hydrate drug combination 1regorafenib 1pevonedistat 1melflufen 1glucarpidase 1gamma-Glutamyl Hydrolase 1copanlisib 1carfilzomib 1Thalidomide 1Methotrexate 1Leucovorin 1L-melphalanyl-p-L-fluorophenylalanine ethyl ester 1Cyclophosphamide 1Bortezomib 1Bendamustine Hydrochloride 1ARQ 197 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Renal Insufficiency × copanlisib × Clear all
NCT03172884 2021-04-28

Study of Copanlisib in Hepatic or Renal Impairment

Bayer

Phase 1 Completed
30 enrolled 20 charts

Hepatic Insufficiency, Renal Insufficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡